reports
Edison issues report on BB Biotech (BION)
Edison Investment Research Limited Edison issues report on BB Biotech (BION) 22-Jan-2025 / 13:31 GMT/BST The issuer is solely responsible for the content of this announcement. London, UK, 22 January 2025 Edison issues report on BB Biotech (BION) Edison issues report on BB Biotech (BION). BB Biotech (BION) is the largest biotech investor among its investment company peers. The company is focused on achieving long-term capital growth by investing in high-quality biotech assets developing and marketing innovative drugs. The new year has started on a very positive note for B...
- Farid Bitari
- Nicolas David
- Sinan Doganli
FME FRESENIUS MEDICAL CARE AG
LHA DEUTSCHE LUFTHANSA AKTIENGESELLSCHAFT
BMW BAYERISCHE MOTOREN WERKE AKTIENGESELLSCHAFT
TEMN TEMENOS AG
TKA THYSSENKRUPP AG
CBK COMMERZBANK AG
BIO BB BIOTECH AG
EKI EKINOPS SA
MRK MERCK KGAA
BAS BASF SE
BAYN BAYER AG
DTE DEUTSCHE TELEKOM AG
SY1 SYMRISE AG
KGX KION GROUP AG
ALFEN ALFEN NV
ALCUR ARCURE SA
SHA SCHAEFFLER AG
- Farid Bitari
- Nicolas David
- Sinan Doganli
FME FRESENIUS MEDICAL CARE AG
LHA DEUTSCHE LUFTHANSA AKTIENGESELLSCHAFT
BMW BAYERISCHE MOTOREN WERKE AKTIENGESELLSCHAFT
TEMN TEMENOS AG
TKA THYSSENKRUPP AG
CBK COMMERZBANK AG
BIO BB BIOTECH AG
EKI EKINOPS SA
MRK MERCK KGAA
BAS BASF SE
BAYN BAYER AG
DTE DEUTSCHE TELEKOM AG
SY1 SYMRISE AG
KGX KION GROUP AG
ALFEN ALFEN NV
ALCUR ARCURE SA
SHA SCHAEFFLER AG
- Martial Descoutures
- Oussema Denguir
- Martial Descoutures
- Oussema Denguir
- Luis de Toledo Heras
ATO ATOS SE
NXI NEXITY SA CLASS A
FLY SOCIETE FONCIERE LYONNAISE SA
MF WENDEL SE
EXE EXEL INDUSTRIES SA
BIO BB BIOTECH AG
MERY MERCIALYS SA
ASY ASSYSTEM SA
WHA WERELDHAVE N.V.
SWP SWORD GROUP SE
CGM CEGEDIM SA
MTU MANITOU BF SA
FII LISI SA
GBT GUERBET SA
ATE ALTEN SA
FR VALEO SE
XIOR XIOR STUDENT HOUSING N.V.
COFB COFINIMMO SA
SAVE SAVENCIA SA
MBWS MARIE BRIZARD WINE & SPIRITS SA
VID VIDRALA SA
TIETO TIETOEVRY OYJ
VIS VISCOFAN S.A.
MONT MONTEA SCA
SIGHT GENSIGHT BIOLOGICS SA
WAF SILTRONIC AG
LIGHT SIGNIFY NV
NVG NAVIGATOR COMPANY SA
A3TV ATRESMEDIA CORPORACION DE MEDIOS DE COMUNICACION SA
LFDE LA FRANCAISE DE L'ENERGIE SA
TEC TECHNIPFMC PLC
XFAB X-FAB SILICON FOUNDRIES SE
SPM SAIPEM S.P.A.
- Luis de Toledo Heras
ATO ATOS SE
NXI NEXITY SA CLASS A
FLY SOCIETE FONCIERE LYONNAISE SA
MF WENDEL SE
EXE EXEL INDUSTRIES SA
BIO BB BIOTECH AG
MERY MERCIALYS SA
ASY ASSYSTEM SA
WHA WERELDHAVE N.V.
SWP SWORD GROUP SE
CGM CEGEDIM SA
MTU MANITOU BF SA
FII LISI SA
GBT GUERBET SA
ATE ALTEN SA
FR VALEO SE
XIOR XIOR STUDENT HOUSING N.V.
COFB COFINIMMO SA
SAVE SAVENCIA SA
MBWS MARIE BRIZARD WINE & SPIRITS SA
VID VIDRALA SA
TIETO TIETOEVRY OYJ
VIS VISCOFAN S.A.
MONT MONTEA SCA
SIGHT GENSIGHT BIOLOGICS SA
WAF SILTRONIC AG
LIGHT SIGNIFY NV
NVG NAVIGATOR COMPANY SA
A3TV ATRESMEDIA CORPORACION DE MEDIOS DE COMUNICACION SA
LFDE LA FRANCAISE DE L'ENERGIE SA
TEC TECHNIPFMC PLC
XFAB X-FAB SILICON FOUNDRIES SE
SPM SAIPEM S.P.A.
- Martial Descoutures
- Oussema Denguir
BB Biotech AG : Q3 in negative territory, the holding continues its re...
>Net loss of CHF 157m in Q3 - BB Biotech this morning announced its Q3 2024 results. The yield on the stock was in negative territory at -9.2% in CHF and -6.7% in € and was negative for the first 9 months of the year at -11% (dividend included). The performance of the portfolio in Q3 stood at -6.6% in CHF, -4.4% in € and -0.6% in $, underperforming the Nasdaq Biotech Index (+5% in $ in the period), but was virtually flat in the first 9 months of the year at +0.3% in ...
- Martial Descoutures
- Oussema Denguir
BB Biotech AG : T3 en territoire négatif, la holding continue sa strat...
>Une perte nette de 157 MCHF au T3 - BB Biotech communique ce matin ses chiffres du T3 2024. Le rendement du titre ressort en territoire négatif à -9.2% en CHF et -6.7% en € et demeure négatif sur les 9 premiers mois de l’année à -11% (dividende inclus). La performance de son portefeuille au T3 ressort à -6.6% en CHF, -4.4% en € et -0.6% en $ sous-performant le Nasdaq Biotech Index (+5% en $ sur la période) mais ressort quasi-flat sur les 9 premiers mois de l’année à ...
Edison issues report on BB Biotech (BION)
Edison Investment Research Limited Edison issues report on BB Biotech (BION) 23-Oct-2024 / 09:12 GMT/BST The issuer is solely responsible for the content of this announcement. London, UK, 23 October 2024 Edison issues report on BB Biotech (BION) Edison issues report on BB Biotech (BION). BB Biotech (BION) invests in innovative, rapidly expanding biotech companies. BION’s portfolio company Wave Life Sciences (Wave) recently announced a significant milestone in the field of genetic medicine: the first successful therapeutic RNA editing in humans. This news lifted Wave’s sh...
- Pedro Fonseca
BB Biotech - A key milestone with significance for the sector
BB Biotech (BION) invests in innovative, rapidly expanding biotech companies. BION’s portfolio company Wave Life Sciences (Wave) recently announced a significant milestone in the field of genetic medicine: the first successful therapeutic RNA editing in humans. This news lifted Wave’s share price by c 60%. It follows recent positive developments in three of BION’s largest holdings, Alnylam, Intra-Cellular Therapies and Agios, which all saw substantial improvements in their longer-term revenue pr...
BB Biotech AG: 1 director
A director at BB Biotech AG bought 1,244 shares at 37.864CHF and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
- Pedro Fonseca
BB Biotech - Lower rates and news flow to support recovery
BB Biotech (BION) offers investors exposure to the innovative, rapidly expanding biotech sector. It is the largest biotech investor among its investment company peers, focused on high-quality biotech assets that target substantial market opportunities. The company recently released its interim report for the period ended 30 June 2024, which provided an update on recent performance and developments with portfolio companies, and outlined the major milestones expected from these holdings during the...
- Jerôme Bodin
PROX PROXIMUS SA DE DROIT PUBLIC
BEKB BEKAERT SA
VCT VICAT-CIMENTS VICAT SA
BFIT BASIC-FIT NV
GTT GAZTRANSPORT & TECHNIGAZ SA
NXI NEXITY SA CLASS A
TFI TELEVISION FRANCAISE 1 SA
BIO BB BIOTECH AG
ALCLA CLASQUIN SA
DEC JCDECAUX SA
ASY ASSYSTEM SA
BLC BASTIDE LE CONFORT MEDICAL SA
ALTR ALTRI SGPS SA
CGM CEGEDIM SA
SRP SRP GROUPE SA
FII LISI SA
LSS LECTRA SA
LNA LNA SANTE SA
GBT GUERBET SA
GOE GROUPE GORGE SA
ATE ALTEN SA
FR VALEO SE
ERA ERAMET SA
COFB COFINIMMO SA
MBWS MARIE BRIZARD WINE & SPIRITS SA
SOC SUBSEA 7 S.A.
ROYAL VOPAK NV
SESL SES-IMAGOTAG SA
SEFER SERGEFERRARI GROUP SA
WAF SILTRONIC AG
WBD WEBUILD S.P.A.
INSD VERIMATRIX SA
SPIE SPIE SA
TEC TECHNIPFMC PLC
XFAB X-FAB SILICON FOUNDRIES SE
HOME NEINOR HOMES SA
SMCP SMCP SA
BFSA BEFESA SA
VOS VOSSLOH AG
2CRSI 2CRSI SA
NEOEN NEOEN S.A.
HAG HENSOLDT AG
VK VALLOUREC SA
ALHRS HYDROGEN REFUELING SOLUTIONS
FORSE FORSEE POWER SA
SPM SAIPEM S.P.A.
FLOW FLOW TRADERS LTD
AF AIR FRANCE - KLM
- Jerôme Bodin
PROX PROXIMUS SA DE DROIT PUBLIC
BEKB BEKAERT SA
VCT VICAT-CIMENTS VICAT SA
BFIT BASIC-FIT NV
GTT GAZTRANSPORT & TECHNIGAZ SA
NXI NEXITY SA CLASS A
TFI TELEVISION FRANCAISE 1 SA
BIO BB BIOTECH AG
ALCLA CLASQUIN SA
DEC JCDECAUX SA
ASY ASSYSTEM SA
BLC BASTIDE LE CONFORT MEDICAL SA
ALTR ALTRI SGPS SA
CGM CEGEDIM SA
SRP SRP GROUPE SA
FII LISI SA
LSS LECTRA SA
LNA LNA SANTE SA
GBT GUERBET SA
GOE GROUPE GORGE SA
ATE ALTEN SA
FR VALEO SE
ERA ERAMET SA
ELIS ELIS SA
COFB COFINIMMO SA
MBWS MARIE BRIZARD WINE & SPIRITS SA
SOC SUBSEA 7 S.A.
ROYAL VOPAK NV
SESL SES-IMAGOTAG SA
SEFER SERGEFERRARI GROUP SA
WAF SILTRONIC AG
WBD WEBUILD S.P.A.
INSD VERIMATRIX SA
SPIE SPIE SA
TEC TECHNIPFMC PLC
XFAB X-FAB SILICON FOUNDRIES SE
HOME NEINOR HOMES SA
SMCP SMCP SA
BFSA BEFESA SA
VOS VOSSLOH AG
2CRSI 2CRSI SA
NEOEN NEOEN S.A.
S30 SOLUTIONS 30 SE
HAG HENSOLDT AG
VK VALLOUREC SA
ALHRS HYDROGEN REFUELING SOLUTIONS
FORSE FORSEE POWER SA
SPM SAIPEM S.P.A.
FLOW FLOW TRADERS LTD
AF AIR FRANCE - KLM
- Martial Descoutures
- Oussema Denguir
BB Biotech AG : Q2 in decline after a good start to the year
>Net loss of CHF 87m in Q2 - BB Biotech reported its Q2 2024 figures this morning. Over the period, the share price has shed -12% in CHF and -11.3% in euros. The performance of its portfolio, while it is better quality compared to the share price, is in negative territory at -3.5% in CHF, -2.6% in € and -3.3% in USD, underperforming the benchmark Nasdaq Biotech Index (+2.8% in $ over the period). This results in a net loss of -CHF 87m vs -CHF 13m in the same period fo...
- Martial Descoutures
- Oussema Denguir
BB Biotech AG : Un T2 en recul après un bon début d’année
>Une perte nette de 87 MCHF sur le T2 - BB Biotech publie ce matin ses chiffres du T2 2024. Le cours de la holding a reculé sur la période de 12% en CHF et de 11.3% en €. La performance de son portefeuille même si elle est de meilleure facture par rapport au cours ressort en territoire négatif à -3.5% en CHF, -2.6% en € et -3.3% en USD sous-performant l’indice de référence le Nasdaq Biotech Index (+2.8% en $ sur la période). Il en ressort une perte nette de -87 MCHF c...
EQS-News: Substanzielle Fortschritte einiger Portfoliounternehmen fede...
EQS-News: BB BIOTECH AG / Schlagwort(e): Zwischenbericht Substanzielle Fortschritte einiger Portfoliounternehmen federn zinsbedingte Marktvolatilität ab 26.07.2024 / 07:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Medienmitteilung vom 26. Juli 2024 Portfolio der BB Biotech AG per 30. Juni 2024 Substanzielle Fortschritte einiger Portfoliounternehmen federn zinsbedingte Marktvolatilität ab Während die Aktienmärkte, angeführt von einigen grossen Technologieunternehmen, neue Höchststände erreichten, blieb der Gesundheitssektor im...
EQS-News: Substantial pipeline progress at several portfolio companies...
EQS-News: BB BIOTECH AG / Key word(s): Interim Report Substantial pipeline progress at several portfolio companies offsets rate-related market volatility 26.07.2024 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. Media release as at July 26, 2024 Portfolio of BB Biotech AG as at June 30, 2024 Substantial pipeline progress at several portfolio companies offsets rate-related market volatility Global equity indices climbed to new record highs during the second quarter, driven by just a few mega tech stocks, but investors continued t...
- Anthony Dick
- Hela Zarrouk
- Thomas Zlowodzki
ODDO BHF Small & MIDCAP MORNING NEWS - 07/17/2024
After a disappointing performance (down 21% since the IPO), we have decided to take our losses on Daimler Truck following its Q2 2024 results release, in which the company decided to write down the value of its Chinese joint venture by € 120m in a ‘persistently weak market environment’. - ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.